BTSG BrightSpring Health Services, Inc.
Services-Home Health Care Services · Nasdaq · SEC CIK 1865782 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY26.0%
TTM net income YoY216.6%
TTM EPS YoY204.9%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin12.5%
Operating margin3.4%
Net margin2.7%
FCF margin3.2%
EBITDA margin4.5%
Returns
ROE20.5%
ROA6.7%
ROIC (approx.)11.0%
Asset turnover2.48x
Leverage & solvency
Liabilities / assets65.1%
Debt / equity1.00x
Current ratio1.62x
Interest coverage3.59x
Cash quality & payout
Operating cash flow / net income1.47x
Accruals ratio-3.1%
Payout ratio—
Capex / revenue0.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $12.91B | $10.07B |
| Gross profit | $1.52B | $1.27B |
| SG&A expense | $1.22B | $1.16B |
| Operating income | $295.25M | $107.95M |
| Interest expense | $157.31M | $190.55M |
| Pretax income | $137.94M | -$95.32M |
| Income tax | $33.15M | -$26.39M |
| Net income | $190.67M | -$18.06M |
| EBITDA | $459.53M | $312.44M |
| EPS (basic) | 0.94 | -0.09 |
| EPS (diluted) | 0.87 | -0.09 |
| Weighted avg. shares (diluted) | 219.77M | 193.00M |
| Balance sheet | ||
| Cash & equivalents | $88.37M | $60.95M |
| Receivables | $989.72M | $902.78M |
| Inventory | $815.18M | $636.56M |
| Current assets | $2.89B | $1.89B |
| PP&E, net | $204.69M | $180.57M |
| Goodwill | $2.55B | $2.36B |
| Intangibles | $557.55M | $595.22M |
| Total assets | $6.41B | $5.93B |
| Current liabilities | $1.85B | $1.43B |
| Short-term debt | $52.34M | $48.73M |
| Long-term debt | $2.46B | $2.56B |
| Total debt | $2.51B | $2.61B |
| Total liabilities | $4.53B | $4.27B |
| Shareholders' equity | $1.88B | $1.65B |
| Net debt | $2.42B | $2.55B |
| Shares outstanding | 192.12M | 174.25M |
| Cash flow statement | ||
| Operating cash flow | $490.17M | $23.77M |
| Capital expenditure | $95.48M | $80.91M |
| Free cash flow | $394.69M | -$57.14M |
| Investing cash flow | -$305.08M | -$140.24M |
| Financing cash flow | -$157.87M | $164.65M |
| Depreciation & amortization | $164.28M | $204.48M |
| Stock-based compensation | $70.10M | $69.17M |
| Share buybacks | $43.17M | $650,000 |
Free plan shows the latest 2 periods; Pro shows all 4 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.